Dialogue Health Technologies Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Dialogue Health Technologies has been growing earnings at an average annual rate of 7.2%, while the Healthcare industry saw earnings declining at 6.7% annually. Revenues have been growing at an average rate of 29.6% per year.
Belangrijke informatie
7.2%
Groei van de winst
22.9%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | -6.7% |
| Inkomstengroei | 29.6% |
| Rendement op eigen vermogen | -21.5% |
| Nettomarge | -20.3% |
| Laatste winstupdate | 30 Jun 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price
Mar 14
Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 17An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued
Jun 28An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued
Feb 11Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)
Nov 07Opbrengsten en kosten
Hoe Dialogue Health Technologies geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 23 | 96 | -20 | 61 | 12 |
| 31 Mar 23 | 92 | -20 | 59 | 11 |
| 31 Dec 22 | 87 | -25 | 57 | 11 |
| 30 Sep 22 | 80 | -23 | 49 | 11 |
| 30 Jun 22 | 74 | -23 | 45 | 10 |
| 31 Mar 22 | 69 | -23 | 42 | 10 |
| 31 Dec 21 | 65 | -248 | 40 | 9 |
| 30 Sep 21 | 63 | -251 | 43 | 8 |
| 30 Jun 21 | 53 | -251 | 39 | 6 |
| 31 Mar 21 | 47 | -247 | 35 | 6 |
| 31 Dec 20 | 36 | -21 | 30 | 5 |
| 31 Dec 19 | 10 | -12 | 14 | 3 |
| 31 Dec 18 | 4 | -10 | 8 | 3 |
Kwaliteitswinsten: CARE is currently unprofitable.
Groeiende winstmarge: CARE is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CARE is unprofitable, but has reduced losses over the past 5 years at a rate of 7.2% per year.
Versnelling van de groei: Unable to compare CARE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: CARE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-38.5%).
Rendement op eigen vermogen
Hoge ROE: CARE has a negative Return on Equity (-21.47%), as it is currently unprofitable.